Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,062.00
Bid: 12,884.00
Ask: 9,725.00
Change: -94.00 (-0.77%)
Spread: -3,159.00 (-24.519%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Upbeat corporate guidances lift European shares, Nvidia forecast boosts chip stocks

Thu, 23rd Feb 2023 17:22

UK healthcare giants fall on ex-dividend trades

*

WPP leads gains among media stocks

*

AXA rises on guidance hike, surprise share buy-back

*

Rolls-Royce jumps on upbeat profit outlook for 2023

*

Euro zone inflation marginally higher in Jan; core also lifted

*

STOXX 600 up 0.1%

Feb 23 (Reuters) - European shares inched higher on Thursday, after two straight sessions of declines, supported by financial stocks and upbeat guidance by regional companies, while U.S. semiconductor designer Nvidia's positive sales forecast sparked a rally in chip stocks.

The pan-European STOXX 600 index rose 0.1%.

AXA

rose 3.2% after the French insurer raised its 2023 guidance and announced a share buy-back programme, while posting lower-than-expected full-year earnings.

Banks gained 0.9%, while insurers added 0.3%.

Also aiding sentiment, data earlier in the day showed that euro zone inflation was only a

touch higher

than earlier estimated in January, confirming that price growth is now well past its peak.

The rate-sensitive technology sector rose 0.4%, supported by a jump in semiconductor stocks.

Chipmakers ASM International, BE Semiconductor and Aixtron gained between 0.4% and 1.2%.

U.S. peer Nvidia Corp forecast first-quarter revenue above Wall Street estimates on Wednesday, noting a strong boost from the use of its chips in artificial intelligence (AI) services such as chatbots.

The shorter-term demand for chips will get a boost to fuel "an AI gold rush, if you think such a phenomenon will actually materialize," said Greg Bassuk, chief executive at AXS Investments.

However, the worries of central banks raising interest rates for longer still lingered.

The minutes from the U.S. Federal Reserve's last policy meeting released on Wednesday showed nearly all policymakers rallied behind a decision to further slow the pace of interest rate hikes, noting inflation would determine how much further rates needed to rise.

"The starkest takeaway was, arguably, that some policymakers could have gotten behind another 50 basis point increase and all backed further tightening ahead," said Craig Erlam, senior market analyst at OANDA.

Recent data showed French and German economic activity moved into growth territory, while a rebound in U.S. business activity also backed views that interest rates in both economies will remain higher for longer.

Still, the STOXX 600 has risen nearly 9% so far this year, more than double the S&P 500 index's 3.9% rise.

Europe has benefited from better weather, hopes that the economy will narrowly avoid a recession and a boost from China's reopening.

Engineering firm Rolls-Royce surged 23.7%, to the top of the STOXX 600, after the company's CEO forecast more profit growth in 2023 after last year's profit beat expectations.

Auto stocks rose 1.0%, with carmaker Stellantis up 3.6%.

Media stocks were up 0.3%, boosted by a 3.4% rise in British ad group WPP after it forecast better-than-expected organic growth of 3% to 5% for the year.

UK banks and healthcare majors fell, weighing on the FTSE 100 index. Barclays, Standard Chartered , AstraZeneca and GSK fell as they traded without an entitlement for dividend payout. (Reporting by Shreyashi Sanyal in Bengaluru; Editing by Subhranshu Sahu, Savio D'Souza and Andrew Heavens)

More News
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.